MarketCap
Facebook
X
TelegramItamar Medical Ltd. Gesamtverbindlichkeiten 2011-2026 | ITMR
Gesamtverbindlichkeiten Jährlich Itamar Medical Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 21.1 M | 16.5 M | 11.7 M | 19.9 M | 30.3 M | 26.8 M | 29.3 M | 38.4 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 38.4 M | 11.7 M | 24.3 M |
Gesamtverbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 14.07 | 0.21 % | $ 2.11 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
281 M | $ 6.86 | 3.63 % | $ 493 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
13.8 M | $ 13.12 | -13.44 % | $ 355 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
92.8 M | $ 31.16 | -0.21 % | $ 1.43 B | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.49 | -2.18 % | $ 167 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
82 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.4 | -0.58 % | $ 118 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 24.27 | 2.1 % | $ 205 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.79 B | $ 269.99 | 0.13 % | $ 7.62 B | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 40.1 | 0.53 % | $ 5.98 K | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 74.86 | 1.87 % | $ 111 B | USA |
 |
InMode Ltd.
INMD
|
83.2 M | $ 14.01 | 0.32 % | $ 906 M | Israel |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
IRadimed Corporation
IRMD
|
11.5 M | $ 101.93 | 1.42 % | $ 1.29 B | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 46.53 | 1.2 % | $ 1.44 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 70.52 | 0.33 % | $ 3.85 B |  Britain |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
43.4 B | $ 96.9 | 0.25 % | $ 125 B | USA |
 |
MiMedx Group
MDXG
|
86.1 M | $ 5.07 | -4.06 % | $ 749 M | USA |
 |
Delcath Systems
DCTH
|
7.84 M | $ 9.12 | -10.68 % | $ 260 M | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
20.9 M | $ 2.44 | -0.41 % | $ 143 M | Israel |
 |
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
294 M | $ 75.24 | -3.9 % | $ 2.12 B |  Costa-rica |
 |
Insulet Corporation
PODD
|
1.68 B | $ 251.19 | 1.24 % | $ 17.7 B | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Quanterix Corporation
QTRX
|
78.1 M | $ 6.11 | -2.86 % | $ 230 M | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.55 | -0.19 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
6.59 M | $ 2.9 | -1.36 % | $ 10.8 M | USA |
 |
Globus Medical
GMED
|
730 M | $ 95.66 | -0.58 % | $ 12.9 B | USA |